Table 2.
The components and effects of Schisandra chinensis detected by MS.
| Types | MS methods | Components | Effects | References |
|---|---|---|---|---|
| Polyphenols | HPLC-ESI-MS | Cya-3-O-xylrut | Antioxidant | (37) |
| GC–MS; ESI-TQMS | Cyanidin 3-Rutinoside | Inhibiting allergic inflammation | (39) | |
| Lignans | HPLC-ESI-TOF-MS | Gomisin D | scavenging ABTS+ radicals | (46) |
| SFC-DAD | schisandrin | Regulating the gut microbiota; Antidepressant | (48) | |
| UPLC-Q-TOF-MS | schisandrol A | Inhibiting pulmonary fibrosis; Improving symptoms of acute myocardial ischemia | (49, 50) | |
| UHPLC | Schisandrin B | Inhibiting hepatic steatosis and promoted fatty acid oxidation and improving NAFLD | (58) | |
| HPLC | Schisandrol A; gomisin N | promoting testosterone biosynthesis | (68) | |
| HPLC–MS/MS | Schisandrin C | Inhibiting the production and trypsin levels | (69) | |
| HPLC-ESI-MS | Schisantherin A | Improving the learning and memory abilities of chronic fatigue mice | (74) | |
| LC-MS/MS | schisandrol B(gomisin A) | Improving APAP-induced acute hepatotoxicity and promoting liver regeneration | (77) | |
| HR-EI-MS | gomisin L1 | Anti-HIV | (80) | |
| HPLC | α-Iso-cubebene | Inhibiting vascular inflammation with subsequent intimal hyperplasia related to vascular injury | (82) | |
| Triterpenoids | HR-ESI-MS | schinchinenlactone D, Propinic lactone A, Schisanbilactone A | Inhibiting inflammation | (92) |
| Organic acids | HPLC; GC-MS | Levulinic acid | Inhibiting the excessive hyperfunction of small intestinal propulsion | (102) |
| Polysaccharide | HPLC | WSP | Improving the gut microbiota and antibiotic-associated diarrhea | (113) |
| GC–MS | SCPP11 | Improving immune response and anti-tumor effects | (115) | |
| GPC; GC-MS | polysaccharide-1 | Alleviating airway inflammation in chronic cough guinea pigs to exert antitussive effects | (116) | |
| HPLC-GC-MS; FTIR | SCP2-1 | Improving LPS-induced cognitive dysfunction in mice and ameliorating excessive inflammatory response | (117) | |
| UPLC-Q-TOF-MS | SCP2 | Improving cognitive dysfunction and reversing the metabolic profile disorder in Alzheimer’s disease rats | (118) | |
| HPLC; GC-MS | SCPP22 | Reversing PCB126-induced immunosuppression | (119) |
DAD, diode array detection; EI, electron ionization; ESI, electrospray ionization; FTIR, fourier transform infrared spectroscopy; GC, gas chromatography; GPC, gel permeation chromatography; HPLC, high performance liquid chromatography; HR, high-resolution; LC, liquid chromatography; MS, mass spectrometry; NAFLD, non alcoholic fatty liver disease; Q-TOF, quadrupole time of flight; SFC, supercritical fluid chromatography; TQ, triple quadrupole; UHPLC,ultra high performance liquid chromatography; UPLC, ultra performance liquid chromatography; WSP, water-soluble polysaccharides.